skip to main content

DOE PAGESDOE PAGES

Title: Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells

Authors:
; ;
Publication Date:
Type:
Publisher's Accepted Manuscript
Journal Name:
Biochemical and Biophysical Research Communications
Additional Journal Information:
Journal Volume: 473; Journal Issue: 4; Related Information: CHORUS Timestamp: 2018-09-13 17:51:15; Journal ID: ISSN 0006-291X
Publisher:
Elsevier
Sponsoring Org:
USDOE
Country of Publication:
United States
Language:
English
OSTI Identifier:
1355602

Yao, Jingyun, Wei, Xing, and Lu, Yanhua. Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells. United States: N. p., Web. doi:10.1016/j.bbrc.2016.03.141.
Yao, Jingyun, Wei, Xing, & Lu, Yanhua. Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells. United States. doi:10.1016/j.bbrc.2016.03.141.
Yao, Jingyun, Wei, Xing, and Lu, Yanhua. 2016. "Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells". United States. doi:10.1016/j.bbrc.2016.03.141.
@article{osti_1355602,
title = {Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells},
author = {Yao, Jingyun and Wei, Xing and Lu, Yanhua},
abstractNote = {},
doi = {10.1016/j.bbrc.2016.03.141},
journal = {Biochemical and Biophysical Research Communications},
number = 4,
volume = 473,
place = {United States},
year = {2016},
month = {5}
}